http://www.fpnotebook.com/
KavaAka: Kava Kava
- Indications
- Mechanism
- Potentiates GABA neurotransmitters
- Adverse Effects
- Serious Extrapyramidal Side Effects
- Excessive Sedation when used with other CNS depressants
- May exacerbate Parkinson's Disease
- Platelet Dysfunction
- Dermopathy or Photosensitivity
- Pruritic Red Papules and Plaques
- May be related to Sun Exposure after kava ingestion
- Hepatotoxicity
- Unclear mechanism and incomplete data
- Some cases progressed to liver failure
- Anke (2004) Planta Med 70(3):193
- Drug Interactions
- Multiple cytochrome P450 interactions
- Additive effects with CNS Depressants
- Benzodiazepines
- Barbiturates
- Antipsychotics
- Alcohol
- Precautions
- Avoid use longer than 24 weeks
- Discontinue at least 24 hours before surgery
- May potentiate perioperative anesthesia
- Efficacy
- Mildly effective in Anxiety Disorder
- References
Kava preparation (C0939882) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| English | KAVA, Kava extract, KAVA EXTRACT PREPARATION, Kava kava, Kava preparation, Piper Methysticum |
| Spanish | extracto de kava, preparacion con kava |
| Parent Concepts | Kava preparation (C0939882), Unclassified Ingredients (C1372954), Unclassified Ingredient Preparations (C1377282), Medicinal Herbs (C0025125), Plant product (C0032088), Over the counter healthfood/herbal products (C0361218), Drug allergen (C1320237), Herbal medicine agent (C1636187) |
| Sources | MTH, NDFRT, RXNORM, SCTSPA, SNOMEDCT, VANDF Derived from the NIH UMLS (Unified Medical Language System) |